Literature DB >> 35366134

The synthesis and properties of mitochondrial targeted iron chelators.

Agostino Cilibrizzi1, Charareh Pourzand2,3, Vincenzo Abbate1, Olivier Reelfs2, Laura Versari1, Giuseppe Floresta1, Robert Hider4.   

Abstract

Iron levels in mitochondria are critically important for the normal functioning of the organelle. Abnormal levels of iron and the associated formation of toxic oxygen radicals have been linked to a wide range of diseases and consequently it is important to be able to both monitor and control levels of the mitochondrial labile iron pool. To this end a series of iron chelators which are targeted to mitochondria have been designed. This overview describes the synthesis of some of these molecules and their application in monitoring mitochondrial labile iron pools and in selectively removing excess iron from mitochondria.
© 2022. The Author(s).

Entities:  

Keywords:  Chelator synthesis; Iron chelation; Iron-probe; Mitochondria

Year:  2022        PMID: 35366134     DOI: 10.1007/s10534-022-00383-8

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  38 in total

1.  Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator.

Authors:  Roxana Y P Alta; Hector A Vitorino; Dibakar Goswami; M Terêsa Machini; Breno P Espósito
Journal:  Biometals       Date:  2017-08-02       Impact factor: 2.949

2.  Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.

Authors:  J R Connor; B S Snyder; J L Beard; R E Fine; E J Mufson
Journal:  J Neurosci Res       Date:  1992-02       Impact factor: 4.164

Review 3.  Iron, oxidative stress and the example of solar ultraviolet A radiation.

Authors:  Asma Aroun; Julia Li Zhong; Rex M Tyrrell; Charareh Pourzand
Journal:  Photochem Photobiol Sci       Date:  2011-10-11       Impact factor: 3.982

4.  Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

Authors:  David Devos; Caroline Moreau; Jean Christophe Devedjian; Jérome Kluza; Maud Petrault; Charlotte Laloux; Aurélie Jonneaux; Gilles Ryckewaert; Guillaume Garçon; Nathalie Rouaix; Alain Duhamel; Patrice Jissendi; Kathy Dujardin; Florent Auger; Laura Ravasi; Lucie Hopes; Guillaume Grolez; Wance Firdaus; Bernard Sablonnière; Isabelle Strubi-Vuillaume; Noel Zahr; Alain Destée; Jean-Christophe Corvol; Dominik Pöltl; Marcel Leist; Christian Rose; Luc Defebvre; Philippe Marchetti; Z Ioav Cabantchik; Régis Bordet
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 5.  Antioxidant defense mechanisms and its dysfunctional regulation in the mitochondrial disease, Friedreich's ataxia.

Authors:  S Chiang; M L H Huang; K C Park; D R Richardson
Journal:  Free Radic Biol Med       Date:  2020-07-30       Impact factor: 7.376

6.  Hydroxypyridinone Journey into Metal Chelation.

Authors:  Agostino Cilibrizzi; Vincenzo Abbate; Yu-Lin Chen; Yongmin Ma; Tao Zhou; Robert C Hider
Journal:  Chem Rev       Date:  2018-07-23       Impact factor: 60.622

7.  Design of novel fluorescent mitochondria-targeted peptides with iron-selective sensing activity.

Authors:  Vincenzo Abbate; Olivier Reelfs; Robert C Hider; Charareh Pourzand
Journal:  Biochem J       Date:  2015-05-26       Impact factor: 3.857

8.  Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice.

Authors:  Suzanne M Cloonan; Kimberly Glass; Maria E Laucho-Contreras; Abhiram R Bhashyam; Morgan Cervo; Maria A Pabón; Csaba Konrad; Francesca Polverino; Ilias I Siempos; Elizabeth Perez; Kenji Mizumura; Manik C Ghosh; Harikrishnan Parameswaran; Niamh C Williams; Kristen T Rooney; Zhi-Hua Chen; Monica P Goldklang; Guo-Cheng Yuan; Stephen C Moore; Dawn L Demeo; Tracey A Rouault; Jeanine M D'Armiento; Eric A Schon; Giovanni Manfredi; John Quackenbush; Ashfaq Mahmood; Edwin K Silverman; Caroline A Owen; Augustine M K Choi
Journal:  Nat Med       Date:  2016-01-11       Impact factor: 53.440

9.  Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.

Authors:  Roxana Y P Alta; Hector A Vitorino; Dibakar Goswami; Cleber W Liria; Simon P Wisnovsky; Shana O Kelley; M Terêsa Machini; Breno P Espósito
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

10.  A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients.

Authors:  Cláudia M Deus; Susana P Pereira; Teresa Cunha-Oliveira; José Teixeira; Rui F Simões; Fernando Cagide; Sofia Benfeito; Fernanda Borges; Nuno Raimundo; Paulo J Oliveira
Journal:  Redox Biol       Date:  2021-06-08       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.